Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E MacDonald

Showing results (881-890 of 1,304) with videos related to

Pageof 131
Sort By:
JAMA|June 8, 2021
Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health OutcomesAzar Mehrabadi, Linda Dodds, Noni E MacDonald, et al.
Human Molecular Genetics|March 26, 2002
Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in miceVanessa C Wheeler, Claire-Anne Gutekunst, Vladimir Vrbanac, et al.
The Journal of Pediatrics|July 1, 1989
Influenza in children with cancerA Kempe, C B Hall, N E MacDonald, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|March 3, 2017
Immunization information systems in Canada: Attributes, functionality, strengths and challenges. A Canadian Immunization Research Network studySarah E Wilson, Susan Quach, Shannon E MacDonald, et al.
Journal of Human Genetics|July 13, 2019
Full sequence of mutant huntingtin 3'-untranslated region and modulation of its gene regulatory activity by endogenous microRNAKyung-Hee Kim, Kawther Abu Elneel, Jun Wan Shin, et al.
Islets|August 4, 2024
Human research islet cell culture outcomes at the Alberta Diabetes Institute IsletCoreJames G Lyon, Alice Lj Carr, Nancy P Smith, et al.
Journal of Huntington'S Disease|October 8, 2015
The Genetic Modifiers of Motor OnsetAge (GeM MOA) Website: Genome-wide Association Analysis for Genetic Modifiers of Huntington's DiseaseKevin Correia, Denise Harold, Kyung-Hee Kim, et al.
Elife|February 21, 2022
P2Y1 purinergic receptor identified as a diabetes target in a small-molecule screen to reverse circadian β-cell failureBiliana Marcheva, Benjamin J Weidemann, Akihiko Taguchi, et al.
Science (New York, N.Y.)|June 16, 2001
Loss of huntingtin-mediated BDNF gene transcription in Huntington's diseaseC Zuccato, A Ciammola, D Rigamonti, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 7, 2015
Haplotype analysis of the 4p16.3 region in Portuguese families with Huntington's diseaseEliana Marisa Ramos, Tammy Gillis, Jayalakshmi S Mysore, et al.
Pageof 131

Showing results (881-890 of 1,304) with videos related to

Sort By:
Pageof 131
JAMA|June 8, 2021
Association of Maternal Influenza Vaccination During Pregnancy With Early Childhood Health OutcomesAzar Mehrabadi, Linda Dodds, Noni E MacDonald, et al.
Human Molecular Genetics|March 26, 2002
Early phenotypes that presage late-onset neurodegenerative disease allow testing of modifiers in Hdh CAG knock-in miceVanessa C Wheeler, Claire-Anne Gutekunst, Vladimir Vrbanac, et al.
The Journal of Pediatrics|July 1, 1989
Influenza in children with cancerA Kempe, C B Hall, N E MacDonald, et al.
Canadian Journal of Public Health = Revue Canadienne De Sante Publique|March 3, 2017
Immunization information systems in Canada: Attributes, functionality, strengths and challenges. A Canadian Immunization Research Network studySarah E Wilson, Susan Quach, Shannon E MacDonald, et al.
Journal of Human Genetics|July 13, 2019
Full sequence of mutant huntingtin 3'-untranslated region and modulation of its gene regulatory activity by endogenous microRNAKyung-Hee Kim, Kawther Abu Elneel, Jun Wan Shin, et al.
Islets|August 4, 2024
Human research islet cell culture outcomes at the Alberta Diabetes Institute IsletCoreJames G Lyon, Alice Lj Carr, Nancy P Smith, et al.
Journal of Huntington'S Disease|October 8, 2015
The Genetic Modifiers of Motor OnsetAge (GeM MOA) Website: Genome-wide Association Analysis for Genetic Modifiers of Huntington's DiseaseKevin Correia, Denise Harold, Kyung-Hee Kim, et al.
Elife|February 21, 2022
P2Y1 purinergic receptor identified as a diabetes target in a small-molecule screen to reverse circadian β-cell failureBiliana Marcheva, Benjamin J Weidemann, Akihiko Taguchi, et al.
Science (New York, N.Y.)|June 16, 2001
Loss of huntingtin-mediated BDNF gene transcription in Huntington's diseaseC Zuccato, A Ciammola, D Rigamonti, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 7, 2015
Haplotype analysis of the 4p16.3 region in Portuguese families with Huntington's diseaseEliana Marisa Ramos, Tammy Gillis, Jayalakshmi S Mysore, et al.
Pageof 131